These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10203274)

  • 1. Diagnosis, Tibetan style, underlies small herbal study of advanced breast cancer.
    Randal J
    J Natl Cancer Inst; 1999 Apr; 91(7):587-8. PubMed ID: 10203274
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticancer Chinese herbal medicines.
    Yeh SD
    Am J Chin Med (Gard City N Y); 1973 Jul; 1(2):271-4. PubMed ID: 4359508
    [No Abstract]   [Full Text] [Related]  

  • 3. An herb for every illness?
    Bent S; Avins AL
    Am J Med; 1999 Feb; 106(2):259-60. PubMed ID: 10230757
    [No Abstract]   [Full Text] [Related]  

  • 4. Traditional herbal medicine as adjunctive therapy for breast cancer: A systematic review.
    Kim W; Lee WB; Lee JW; Min BI; Baek SK; Lee HS; Cho SH
    Complement Ther Med; 2015 Aug; 23(4):626-32. PubMed ID: 26275657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional oriental medicine.
    Worrall RS
    Optometry; 2001 Mar; 72(3):147-9. PubMed ID: 11294586
    [No Abstract]   [Full Text] [Related]  

  • 6. Summaries for patients. Chemotherapy in women with breast cancer.
    Ann Intern Med; 2003 Jan; 138(2):I16. PubMed ID: 12529113
    [No Abstract]   [Full Text] [Related]  

  • 7. [Exploration of property theory of Tibetan medicine].
    Wang XY; Tuerdi W; Zhao BS; Shao AJ; Abdulla Megiddo I; Abdu Keremu K; Liu CS
    Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(7):1199-202. PubMed ID: 25011253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating an ER Degrader for Breast Cancer.
    Cancer Discov; 2015 Jul; 5(7):OF15. PubMed ID: 25956960
    [No Abstract]   [Full Text] [Related]  

  • 9. Eribulin in advanced breast cancer: safety, efficacy and new perspectives.
    Garrone O; Miraglio E; Vandone AM; Vanella P; Lingua D; Merlano MC
    Future Oncol; 2017 Dec; 13(30):2759-2769. PubMed ID: 29219017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic applications of medicinal plants in the treatment of breast cancer: a review of their pharmacology, efficacy and tolerability.
    Mantle D; Lennard TW; Pickering AT
    Adverse Drug React Toxicol Rev; 2000 Aug; 19(3):223-40. PubMed ID: 11059361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of microarray technology in the management of breast cancer.
    Pusztai L
    Clin Adv Hematol Oncol; 2007 Mar; 5(3):193-4, 197. PubMed ID: 17519880
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trial design in metastatic breast cancer: a commentary.
    Levine M
    Can J Oncol; 1995 Dec; 5 Suppl 1():40-2. PubMed ID: 8853523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials referral resource. Multicenter phase I and II trials in adults with high-grade gliomas.
    Kaplan RS; Smiley JK; Cheson BD
    Oncology (Williston Park); 1999 Apr; 13(4):532-3, 537. PubMed ID: 10234703
    [No Abstract]   [Full Text] [Related]  

  • 14. Author of CME article offers clarification about Essiac.
    Low Dog T
    Altern Ther Health Med; 2001; 7(4):20. PubMed ID: 11452561
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical development plan: 9-cis-retinoic acid.
    J Cell Biochem Suppl; 1996; 26():158-67. PubMed ID: 9154176
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyrrolizidine alkaloids in medicinal plants of Mongolia, Nepal and Tibet.
    Roeder E; Wiedenfeld H
    Pharmazie; 2009 Nov; 64(11):699-716. PubMed ID: 20099513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum salts in advanced breast cancer: a systematic review and meta-analysis of randomized clinical trials.
    Petrelli F; Barni S; Bregni G; de Braud F; Di Cosimo S
    Breast Cancer Res Treat; 2016 Dec; 160(3):425-437. PubMed ID: 27770282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [San Antonio Breast Cancer Symposium 2003. New therapeutic prospects in the treatment of early-stage breast cancer].
    Montemurro F
    Tumori; 2004; 90(1):suppl 1-16. PubMed ID: 15143995
    [No Abstract]   [Full Text] [Related]  

  • 19. Her2 and trastuzumab in breast cancer.
    Horton J
    Cancer Control; 2001; 8(1):103-10. PubMed ID: 11176040
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials referral resource. Advanced breast cancer.
    Cheson BD
    Oncology (Williston Park); 1989 Jul; 3(7):113-4, 121-3. PubMed ID: 2641908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.